Schneider Eugene
EVP, Chf Clinical Develop Ofcr
Schneider Eugene has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.9M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| IONS | EVP, Chf Clinical Develop Ofcr | Sale | 26,000 | $2.1M | Jun 30 | SEC ↗ | |
| IONS | EVP, Chf Clinical Develop Ofcr | Sale | 5,812 | $412K | Mar 23 | SEC ↗ | |
| IONS | EVP, Chf Clinical Develop Ofcr | Sale | 6,179 | $516K | Feb 2 | SEC ↗ | |
| IONS | EVP, Chf Clinical Develop Ofcr | Sale | 9,302 | $703K | Jan 20 | SEC ↗ | |
| IONS | EVP, Chf Clinical Develop Ofcr | Sale | 19,658 | $1.2M | Sep 4 | SEC ↗ |